189 related articles for article (PubMed ID: 28036334)
1. Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block.
Vicente J; Johannesen L; Hosseini M; Mason JW; Sager PT; Pueyo E; Strauss DG
PLoS One; 2016; 11(12):e0163619. PubMed ID: 28036334
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil.
Vicente J; Johannesen L; Mason JW; Crumb WJ; Pueyo E; Stockbridge N; Strauss DG
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25870186
[TBL] [Abstract][Full Text] [Related]
3. Electrocardiographic biomarkers to confirm drug's electrophysiological effects used for proarrhythmic risk prediction under CiPA.
Vicente J; Hosseini M; Johannesen L; Strauss DG
J Electrocardiol; 2017; 50(6):808-813. PubMed ID: 28928044
[TBL] [Abstract][Full Text] [Related]
4. T vector velocity: A new ECG biomarker for identifying drug effects on cardiac ventricular repolarization.
Bystricky W; Maier C; Gintant G; Bergau D; Kamradt K; Welsh P; Carter D
PLoS One; 2019; 14(7):e0204712. PubMed ID: 31283756
[TBL] [Abstract][Full Text] [Related]
5. Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.
Johannesen L; Vicente J; Mason JW; Sanabria C; Waite-Labott K; Hong M; Guo P; Lin J; Sørensen JS; Galeotti L; Florian J; Ugander M; Stockbridge N; Strauss DG
Clin Pharmacol Ther; 2014 Nov; 96(5):549-58. PubMed ID: 25054430
[TBL] [Abstract][Full Text] [Related]
6. Update on the ECG component of the CiPA initiative.
Vicente J
J Electrocardiol; 2018; 51(6S):S98-S102. PubMed ID: 30121123
[TBL] [Abstract][Full Text] [Related]
7. A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored Consortium.
Boulay E; Abernathy MM; Chui R; Friedrichs GS; Gendron-Parra N; Greiter-Wilke A; Guillon JM; Koerner JE; Menard A; Steidl-Nichols J; Pierson J; Pugsley MK; Rossman EI; Strauss D; Troncy E; Valentin JP; Wisialowski T; Authier S
Int J Toxicol; 2019; 38(1):23-32. PubMed ID: 30567462
[TBL] [Abstract][Full Text] [Related]
8. Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial.
Johannesen L; Vicente J; Mason JW; Erato C; Sanabria C; Waite-Labott K; Hong M; Lin J; Guo P; Mutlib A; Wang J; Crumb WJ; Blinova K; Chan D; Stohlman J; Florian J; Ugander M; Stockbridge N; Strauss DG
Clin Pharmacol Ther; 2016 Feb; 99(2):214-23. PubMed ID: 26259627
[TBL] [Abstract][Full Text] [Related]
9. The algorithmic performance of J-Tpeak for drug safety clinical trial.
Chien SC; Gregg RE
J Electrocardiol; 2017; 50(6):762-768. PubMed ID: 28942951
[TBL] [Abstract][Full Text] [Related]
10. Differentiating multichannel block on the guinea pig ECG: Use of T
Skinner M; Hale E; Ceuppens P; Pollard C
J Pharmacol Toxicol Methods; 2021; 111():107085. PubMed ID: 34182121
[TBL] [Abstract][Full Text] [Related]
11. Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs.
Vicente J; Stockbridge N; Strauss DG
J Electrocardiol; 2016; 49(6):837-842. PubMed ID: 27524478
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study.
Vicente J; Zusterzeel R; Johannesen L; Ochoa-Jimenez R; Mason JW; Sanabria C; Kemp S; Sager PT; Patel V; Matta MK; Liu J; Florian J; Garnett C; Stockbridge N; Strauss DG
Clin Pharmacol Ther; 2019 Apr; 105(4):943-953. PubMed ID: 30447156
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of multiple algorithms for the measurement of the heart rate corrected JTpeak interval.
Couderc JP; Ma S; Page A; Besaw C; Xia J; Chiu WB; de Bie J; Vicente J; Vaglio M; Badilini F; Babaeizadeh S; Chien CS; Baumert M
J Electrocardiol; 2017; 50(6):769-775. PubMed ID: 29021091
[TBL] [Abstract][Full Text] [Related]
14. Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk.
Johannesen L; Vicente J; Hosseini M; Strauss DG
PLoS One; 2016; 11(12):e0166925. PubMed ID: 28036330
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterisation of electrocardiogram J-T
Nogawa H; Muraki Y; Kawai T; Kuninishi Y
Eur J Pharmacol; 2022 Jul; 927():175065. PubMed ID: 35640715
[TBL] [Abstract][Full Text] [Related]
16. How to determine cardiac ion channels targeted by drugs using the isolated rabbit ventricular wedge model.
Liu G; Liu T; Cohen D; Liu T; Yan GX
J Pharmacol Toxicol Methods; 2016; 81():161-70. PubMed ID: 27195944
[TBL] [Abstract][Full Text] [Related]
17. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
Cheng HC; Incardona J
J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
[TBL] [Abstract][Full Text] [Related]
18. Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Wiśniowska B; Mendyk A; Fijorek K; Glinka A; Polak S
J Appl Toxicol; 2012 Oct; 32(10):858-66. PubMed ID: 22761000
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in drug-induced changes in ventricular repolarization.
Vicente J; Johannesen L; Mason JW; Pueyo E; Stockbridge N; Strauss DG
J Electrocardiol; 2015; 48(6):1081-7. PubMed ID: 26324176
[TBL] [Abstract][Full Text] [Related]
20. Classification of drug-induced hERG potassium-channel block from electrocardiographic T-wave features using artificial neural networks.
Morettini M; Peroni C; Sbrollini A; Marcantoni I; Burattini L
Ann Noninvasive Electrocardiol; 2019 Nov; 24(6):e12679. PubMed ID: 31347753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
